4//SEC Filing
Namouni Fouad 4
Accession 0001415889-25-006602
CIK 0001597264other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:16 PM ET
Size
7.1 KB
Accession
0001415889-25-006602
Insider Transaction Report
Form 4
Namouni Fouad
PRESIDENT, R & D
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+26,400→ 26,400 totalExercise: $96.57Exp: 2035-02-28→ Common Stock (26,400 underlying) - Award
Common Stock
2025-03-01+13,200→ 82,270 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of grant of 13,200 restricted stock units under the Issuer's 2024 Stock Incentive Plan.
- [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2025 and as to an additional 1/48th of the shares underlying the option each month thereafter.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001815851
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:16 PM ET
- Size
- 7.1 KB